英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
moxifloxacin hydrochloride
|
186826-86-8 |
盐酸莫西沙星
|
盐酸莫西沙星;莫西沙星HCL;盐酸莫西沙星(CAS号:186826-86-8);盐酸莫西沙星99%;莫西沙星盐酸盐;1-环丙基-7-(S,S-2,8-二氮杂双环[4.3.0]壬烷-8-基)-6-氟-8-甲氧-4-氧代-1,4-二氢-3-喹啉羧酸盐酸;1-环丙基-7-{S,8-重氮-二环[4.3.0]壬-8-基}-6-氟-8-甲氧-1,4-二氢-4-氧-3-喹啉羧酸盐酸盐;AVELOX;AVALOX;1-环丙基-7-(S,8-重氮-二环[4.3.0]壬烷-8-基)-6-氟-8-甲氧-1,4-二氢-4-氧-3-喹啉羧酸盐酸盐
|
C21H24FN3O4.HCL |
437.9 | 641-756-7 |
MLN9708
|
1201902-80-8 |
MLN9708
|
枸橼酸艾沙佐米;埃沙佐米柠檬酸盐4-羧基-2-[(1R)-1-[[2-[(2,5-二氯苯甲酰基)氨基]乙酰基]氨基]-3-甲基丁基]-6-氧代-1,3,2-二氧硼杂环己-4-乙酸;CS-1830;艾沙唑咪;MLN9708;MLN-9708;埃沙左米柠檬酸;艾沙佐米柠檬酸盐;MLN9708,20S蛋白酶体抑制剂
|
C20H23BCl2N2O9 |
517.12162 | |
MLN8054
|
869363-13-3 |
4-[[9-氯-7-(2,6-二氟苯基)-5H-嘧啶并[5,4-D][2]苯并氮杂卓-2-基]氨基]苯甲酸
|
4-[[9-氯-7-(2,6-二氟苯基)-5H-嘧啶并[5,4-D][2]苯并氮杂卓-2-基]氨基]苯甲酸
|
C14H17NO4 |
263.291 | 1592732-453-0 |
MLN4924 (Hydrochloride Salt)
|
1160295-21-5 |
氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氢-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羟基环戊基]甲基酯盐酸盐
|
MLN-4924 盐酸盐;氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氢-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羟基环戊基]甲基酯盐酸盐;PEVONEDISTAT HYDROCHLORIDE;TAK-924 HYDROCHLORIDE;PEVONEDISTAT HYDROCHLORIDE;MLN-4924 HYDROCHLORIDE;MLN 4924 HYDROCHLORIDE
|
C21H25N5O4S.HCl |
479.98024 | 200-258-5 |
MLN4924
|
905579-51-3 |
氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氢-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羟基环戊基]甲基酯
|
氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氢-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羟基环戊基]甲基酯;CS-821;PEVONEDISTAT;MLN-4924
|
C21H25N5O4S |
443.5193 | |
MLN2480 (BIIB-024)
|
1096708-71-2 |
6-氨基-5-氯-N-[(1R)-1-[5-[[[5-氯-4-(三氟甲基)-2-吡啶基]氨基]羰基]-2-噻唑基]乙基]-4-嘧啶甲酰胺
|
6-氨基-5-氯-N-[(1R)-1-[5-[[[5-氯-4-(三氟甲基)-2-吡啶基]氨基]羰基]-2-噻唑基]乙基]-4-嘧啶甲酰胺;BIIB-024;MLN2480;MLN-2480;6-氨基-5-氯-N-[(1R)-1-[5-[[[5-氯-4-(三氟甲基)-2-吡啶]氨基]羰基]-2-噻唑]乙基]-4-嘧啶羧酰胺
|
C17H12Cl2F3N7O2S |
506.28909 | |
ML 7 hydrochloride
|
110448-33-4 |
1-(5-碘萘-1-磺酰基)-1H-六氢-1,4-二氮杂卓盐酸盐
|
ML7;ML 7 HYDROCHLORIDE;CS-755;ML;ML 7;1-(5-碘萘-1-磺酰基)-1H-六氢-1,4-二氮杂卓盐酸盐;1-[(5-碘-1-萘基)磺酰基]-1H-1,4-二氮杂环庚烷盐酸盐;ML-7盐酸盐
|
C15H18ClIN2O2S |
452.74 | |
MK-5108 (VX-689)
|
1010085-13-8 |
MK-5108 (VX-689)
|
CS-545;MK 5108;VX-689;VX 689;MK5108;VX689;反式-4-(3-氯-2-氟苯氧基)-1-[[6-(2-噻唑基氨基)-2-吡啶基]甲基]环己烷甲酸
|
C22H21ClFN3O3S |
461.936843 | |
MK-4827
|
1038915-60-4 |
尼拉帕尼
|
MK 4827;MK-4827;MK4827;-[4-((3S)-3-哌啶基)苯基]-2H-吲唑-7-甲酰胺;(S)-2-(4-(哌啶-3-基)苯基)-2H-吲唑-7-羧酰胺;尼拉帕布;尼拉帕尼(碱);(S)-2-((哌啶-3-基)苯基)-吲唑-7-甲酰胺;2-[4-((3S)-3-哌啶基)苯基]-2H-吲唑-7-甲酰胺;尼拉帕尼
|
C19H20N4O |
320.3883 | |
MK-2894
|
1006036-87-8 |
4-[1-[[[2,5-二甲基-4-[[4-(三氟甲基)苯基]甲基]-3-噻吩基]羰基]氨基]环丙基]苯甲酸
|
MK 2894;MK2894;4-[1-[[[2,5-二甲基-4-[[4-(三氟甲基)苯基]甲基]-3-噻吩基]羰基]氨基]环丙基]苯甲酸
|
C25H22F3NO3S |
473.50729 | |
MK-1775
|
955365-80-7 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基)-6-(4-(4-甲基哌嗪-1-基)苯基氨基)-1H-吡唑并[3,4-D]嘧啶-3(2H)-酮
|
MK1775;AZD-1775;AZD1775;AZD 1775;MK 1775;MK-1775|2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基)-6-(4-(4-甲基哌嗪-1-基)苯基氨基)-1H-吡唑并[3,4-D]嘧啶-3(2H)-酮;2-ALLYL-1-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-2-YL)-6-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)-1H-PYRAZO;2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基)-6-(4-(4-甲基哌嗪-1-基)苯基氨基)-1H-吡唑并[3,4-D]嘧啶-3(2H)-酮;AZD1775;MK-1775;MK1775;2-烯丙基-1-(6-(2-羟基丙烷-2-基)吡啶-2-基)-6-(4-(4-甲基哌嗪-1-基)苯基氨基)-1H-吡唑;CS-605
|
C27H32N8O2 |
500.59538 | |
MK-1439
|
1338225-97-0 |
MK-1439
|
MK-1439;3-chloro-5-((1-((4-Methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)Methyl)-2-oxo-4-(trifluoroMethyl)-1,2-dihydropyridin-3-yl)oxy)benzonitrile;3-Chloro-5-[[1-[(4,5-dihydro-4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]benzonitrile;Doravirine / MK-1439;Doravirine;MK-1439(Doravirine);Benzonitrile, 3-chloro-5-[[1-[(4,5-dihydro-4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]-;3-chloro-5-[1-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile
|
C17H11ClF3N5O3 |
||
fosaprepitant
|
172673-20-0 |
福沙吡坦
|
福沙匹坦 ;福沙匹坦二葡甲胺;福沙吡坦二葡甲胺;福沙匹坦异构体;[3-[[(2R,3S)-2-[(1R)-1-[3,5-双(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)-4-吗啉基]甲基]-2,5-二氢-5-氧代-1H-1,2,4-三唑-2-基]膦酸;福沙吡坦;福沙匹坦二甲基葡胺
|
C23H22F7N4O6P |
614.41 | |
Mizoribine
|
50924-49-7 |
咪唑立宾
|
MIZORIBINE (NSC 289637;HE 69);咪唑利宾;布累迪宁(咪唑立宾);优青糖苷;5-羟基-1-beta-D-呋喃糖基-1H-咪唑-5-羧酰胺;咪唑立宾;咪唑立宾杂质;布累迪宁
|
C9H13N3O6 |
259.22 | 637-144-4 |
mizolastine
|
108612-45-9 |
咪唑司汀
|
咪唑司汀(标准品);咪唑斯汀粗品;2-[[1-[1-[(4-氟苯基)甲基]苯并咪唑-2-基]-4-哌啶基]-甲基氨基]-3H-嘧啶-5-酮;咪唑司汀;咪唑斯汀;咪唑斯汀
|
C24H25FN6O |
432.49 | 1308068-626-2 |
Mitoxantrone hydrochloride
|
70476-82-3 |
盐酸米托蒽醌
|
米托蒽醌盐酸盐;盐酸米托蒽醌(标准品);盐酸米托蒽醌(1,4-二羟基-5,8-双[[2-[(2-羟基乙基)氨基]乙基]氨基]-9,10-蒽醌二盐酸盐、米托蒽醌盐酸盐、盐酸米托恩醌、盐酸米托蒽鲲);盐酸米托蒽醌 5G;1,10-蒽醌二盐酸盐;盐酸米托蒽醌;米托蒽醌二盐酸盐;盐酸米托恩醌
|
C22H30Cl2N4O6 |
517.4028 | 274-619-1 |
Mitotan
|
53-19-0 |
米托坦
|
氯苯二氯乙烷;O,P'-滴滴滴,95%;2,4'-滴滴滴,100ΜG ;ΜL于丙酮;O,P'-滴滴滴溶液,100PPM;2,4'-滴滴滴标准溶液;2,4'-滴滴滴溶液,101PPM;正己烷中O,P-DDD;米托坦 标准品
|
C14H10Cl4 |
320.04 | 200-166-6 |
Mitiglinide calcium
|
145525-41-3 |
米格列奈
|
米格列奈钙一水物;米格列萘钙;双(2S)-2-苄基-3-(顺式全氢异吲哚-2-羰基)丙二酸单钙盐;米格列奈钙及其中间体;米格列奈钙杂质A;米格列奈单钙二水合物;双(2S)-2-苄基-3-(顺式全氢异吲哚-2-羰基)丙酸单钙盐
|
(C19H24NO3)2.Ca |
668.88 | 692-046-9 |
Mirtazapine
|
85650-52-8 |
米氮平
|
米氮平无水物;米氮平无水合物;1,2,3,4,10,14b-六氢-2-甲基吡嗪基-[2,1-a]吡啶并[2,3-C]氮杂卓;米氮平;米尔塔扎平;米氮平-D7;米氮平(标准品);米尔塔扎平,5-HT受体抑制剂
|
C17H19N3 |
265.35 | 288-060-6 |
minoxidil
|
38304-91-5 |
米诺地尔
|
米诺地尔;6-(1-哌啶基)-2,4-嘧啶二胺-4-氧化物;甲基磷酸酯;哌嘧啶二胺;米诺地尔(敏乐啶);敏诺西代;米诺地尔;敏乐啶;长压定;米诺地尔;长压定
|
C9H15N5O |
209.25 |